Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
HighlightsCreative Biolabs can offer you a full development package from proof of concept through to cGMP scale up in mammalian or microbial systems to produce recombinant proteins and biopharmaceutical antibodies.
For theraputic antibodies:
We offer integrated type of services for antibody production in antibody engineering, monoclonal production and cGMP scale up manufacturing.
We are experienced in providing our clients with services including antibody sequencing, scFv/Fab production and humanization for antibody engineering. Sequencing is quite important for patent issues and therapeutic approval; we have developed technologies to convert full monoclonal antibodies from a hybridoma cell line into single chain antibody fragments, which can be expressed in E. coli or CHO cells; humanized antibodies can reduce the human anti-murine antibody response (HAMA) and have a greater half-life in vivo.
Deliverable:
For recombinant proteins:
We provide technical capabilities to help our clients to accelerate their drug development process and make breakthrough discovery in a rapid and cost effective fashion. Our staff have decades of experience in the expression of recombinant proteins for Western pharmaceutical research organizations or companies.
Deliverable:
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
